在帕金森病中,从FGF2主导的天体细胞中衍生出的细胞外囊,用于对抗线粒体和突触毒性
Xiaomin Wen1,2, Wanjun Cao2, Hui Ding2
1College of Life Sciences, Northwest University, Xi'an, Shaanxi, 710069, People's Republic of China.
International journal of nanomedicine
|April 18, 2025
概括
纤维细胞生长因子-2 (FGF2) 主导的星体细胞外细胞囊泡 (EVs) 显示出对帕金森病 (PD) 治疗的希望. 这些FGF2-EVs保护神经元免受线粒体损伤,增强突触连接,改善PD模型中的运动功能.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 线粒体生物学 线粒体生物学
背景情况:
- 帕金森病 (PD) 涉及线粒体功能障碍和突触损失.
- 星体细胞在突触生成中发挥作用,它们的反应性表型在PD中是有害的.
- 纤维细胞生长因子-2 (FGF2) 影响天体细胞的发育和功能.
研究的目的:
- 调查FGF2是否可以逆转反应性天体细胞表型.
- 为了确定FGF2-primed天体细胞的细胞外囊泡 (EV) 是否可以在PD模型中增强突触生成.
- 为了测试FGF2-原始化天体细胞衍生的EVs在PD中的治疗潜力.
主要方法:
- 使用电子显微镜和纳米粒子追踪对FGF2-原始化天体细胞EVs (FGF2-EVs) 的表征.
- 将FGF2-EV和控制EV (CON-EV) 应用于体外和体外PD模型.
- 使用分子和行为试验评估线粒体健康,神经元存活,突触生成和运动行为;用蛋白质组分析和基因沉默来阐明机制.
主要成果:
- FGF2治疗使星球细胞标志物正常化,并改善了神经元健康.
- FGF2-EVs保护神经元免受线粒体碎片化,并促进突触生成,由Mfn2,PSD-95和SYP的增加表明.
- 在PD小鼠中,FGF2-EVs显著改善了神经元的存活,突触生成和运动,神经细胞粘附分子1 (NCAM1) 被确定为关键调解者.
结论:
- 来自FGF2-primed天体细胞的细胞外囊泡在PD模型中表现出优越的治疗效果.
- FGF2-EVs在PD中减轻线粒体和突触毒性,可能通过NCAM1.
- 这些发现表明FGF2-EVs是帕金森病的有希望的治疗策略.
相关概念视频
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
EPS and iPS Cells in Disease Research
2.7K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.7K
Parkinson's Disease: Overview
310
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
310


